Drugs Made in America AcquisDMAA
13F holders, Q4 2025 (December 31)39holders +2
2new positions
1sold out
1famous investor
$10.25avg. 13F price*
At the end of Q4 2025, 39 institutions reported holding Drugs Made in America Acquis (DMAA) in their 13F filings, up 2 from Q3 2025. 2 opened new positions and 1 sold out. The largest holders were Karpus Management, Inc. ($26.3M), First Trust Capital Management L.P. ($23.3M) and Glazer Capital, LLC ($18.8M). One famous investor held it David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Drugs Made in America Acquis
- CUSIP
- G2847J104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $7.6M |
| Exits | 1 | $161K |
All 13F filers, Q3 2025 → Q4 2025: 1,948,012 shares bought and 797,438 shares sold, net +1,150,574 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 39 holders
| Karpus Management, Inc. | 0.81% | Reduce -0.3% | 2,538,642 | $26.3M |
| First Trust Capital Management L.P. | 1.41% | No change | 2,242,500 | $23.3M |
| Glazer Capital, LLC | 0.56% | Reduce -0.3% | 1,816,428 | $18.8M |
| Westchester Capital Management, LLC | 0.82% | No change | 1,669,000 | $17.3M |
| Polar Asset Management Partners Inc. | 0.43% | Reduce -15.8% | 1,600,000 | $16.6M |
| Hudson Bay Capital Management LP | 0.10% | No change | 1,550,000 | $16.1M |
| Mizuho Securities USA LLC | 0.24% | Add +30.3% | 1,433,483 | $14.8M |
| Wolverine Asset Management LLC | 0.79% | Add +4.7% | 1,307,468 | $13.6M |
| Aristeia Capital, L.L.C. | 0.46% | No change | 881,716 | $9.1M |
| Mercuria Capital Strategies, LLC | 4.27% | New | 750,000 | $7.5M |
| D. E. Shaw & Co. | 0.01% | No change | 690,000 | $7.2M |
| Heights Capital Management, Inc. | 2.58% | No change | 650,000 | $6.7M |
| Radcliffe Capital Management, L.P. | 0.80% | Add +3.5% | 546,808 | $5.7M |
| J. Goldman & Co LP | 0.20% | No change | 500,000 | $5.2M |
| LMR Partners LLP | 0.07% | No change | 500,000 | $5.2M |
| Rivernorth Capital Management, LLC | 0.21% | Add +31.4% | 417,998 | $4.3M |
| Whitebox Advisors LLC | 0.26% | No change | 400,000 | $4.1M |
| AQR Arbitrage LLC | 0.10% | No change | 371,211 | $3.8M |
| Boothbay Fund Management, LLC | 0.10% | Reduce -30.8% | 346,154 | $3.6M |
| Quarry LP | 0.47% | Add +1595.5% | 266,551 | $2.8M |
| Governors Lane LP | 0.24% | Add +2132.1% | 250,000 | $2.6M |
| Context Capital Management, LLC | 0.86% | No change | 250,000 | $2.6M |
| Shaolin Capital Management LLC | 0.28% | Add +34.7% | 202,069 | $2.1M |
| L1 Global Manager Pty Ltd | 1.36% | — | 200,000 | $2.1M |
| Toronto Dominion Bank | 0.00% | Reduce -55.6% | 200,000 | $2.1M |
| Bulldog Investors, LLP | 0.30% | No change | 130,264 | $1.4M |
| Goldman Sachs Group Inc. | 0.00% | No change | 119,686 | $1.2M |
| DLD Asset Management, LP | 0.36% | Reduce -11.5% | 100,559 | $1.0M |
| Clear Street Group Inc. | 0.01% | Add +55.5% | 325,973 | $996K |
| Warberg Asset Management LLC | 3.04% | No change | 92,055 | $955K |
| Periscope Capital Inc. | 0.11% | No change | 50,000 | $519K |
| JPMorgan Chase & Co. | 0.00% | Reduce -50.0% | 49,821 | $517K |
| Geode Capital Management, LLC | 0.00% | No change | 45,648 | $473K |
| UBS Group AG | 0.00% | Add +89.7% | 38,159 | $396K |
| Dakota Wealth Management | 0.01% | No change | 36,400 | $377K |
| Lineage Point Capital LP | 0.13% | — | 31,840 | $330K |
| HRT Financial LP | 0.00% | Add +2.9% | 28,282 | $293K |
| Logan Stone Capital, LLC | 0.03% | New | 10,900 | $113K |
| Morgan Stanley | 0.00% | Add +278.1% | 121 | $1K |
"% of holder's portfolio" is DMAA's weight in each manager's 13F, not the share of Drugs Made in America Acquis the manager owns.